| Literature DB >> 27840684 |
Kristian E H Frandsen1, Leila Lo Leggio1.
Abstract
Lytic polysaccharide monooxygenases (LPMOs) are a new class of microbial copper enzymes involved in the degradation of recalcitrant polysaccharides. They have only been discovered and characterized in the last 5-10 years and have stimulated strong interest both in biotechnology and in bioinorganic chemistry. In biotechnology, the hope is that these enzymes will finally help to make enzymatic biomass conversion, especially of lignocellulosic plant waste, economically attractive. Here, the role of LPMOs is likely to be in attacking bonds that are not accessible to other enzymes. LPMOs have attracted enormous interest since their discovery. The emphasis in this review is on the past and present contribution of crystallographic studies as a guide to functional understanding, with a final look towards the future.Entities:
Keywords: biomass degradation; carbohydrate-modifying enzymes; copper enzymes; lytic polysaccharide monooxygenases; metalloproteins
Year: 2016 PMID: 27840684 PMCID: PMC5094447 DOI: 10.1107/S2052252516014147
Source DB: PubMed Journal: IUCrJ ISSN: 2052-2525 Impact factor: 4.769
Figure 1Enzymatic strategies for cleavage of glycosidic linkages. Glycoside hydrolysis of maltose by a retaining (a) or inverting (b) mechanism, polygalacturonan degradation by a polysaccharide lyase (c) and oxidative cleavage of cellooligosaccharides/cellulose by LPMOs (d).
X-ray crystal structures of LPMOs
The key to the footnote markers is given at the end of the table.
| Crystallization and diffraction data | Active site | Specificity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Family | Organism | Protein name | PDB code | ASU | Protein concentration and buffer | Crystallization conditions | Space group | Res. (Å) | Element (oxidation) | Residues | Substrates | Site of attack | Comments | Reference |
| AA9 |
|
|
| 1 | 19.2 mg ml−1, 0.02 | 3.6 |
| 1.80 | Copper(II) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 m | Frandsen |
| AA9 |
|
|
| 1 | 19.2 mg ml−1, 0.02 | 3.9 |
| 1.91 | Copper(II) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 m | Frandsen |
| AA9 |
|
|
| 1 | 8.5 mg ml−1, 0.02 | 3.0 |
| 1.28 | Copper(II)/copper(I) 0.9 | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 m | Frandsen |
| AA9 |
|
|
| 1 | 19.2 mg ml−1, 0.02 | 3.6 |
| 1.75 | Copper(II)/copper(I) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 m | Frandsen |
| AA9 |
|
|
| 1 | 19.2 mg ml−1, 0.02 | 3.0 |
| 1.70 | Copper(I) | MeHis1, His78, Tyr164 | PASC, cellooligosaccharides | C4 | Preincubated with 1 m | Frandsen |
| AA9 |
|
|
| 2 | 0.15 | PEG 3350 (pH 6.7) |
| 1.10 | Copper(II)/copper(I) | MeHis1, His84, Tyr168 | PASC | C4 | Proposed O2 molecule near active-site axial position. | Li |
| AA9 |
|
|
| 2 | — | 0.2 |
| 1.10 | Copper(II) | His1, His72, Tyr157 | PASC | C1 | Regiospecificity in Vu, Beeson, Phillips | Tan |
| AA9 |
|
|
| 2 | 104 mg ml−1, 0.010 | 0.1 |
| 1.37 | Copper(I) | MeHis1, His82, Tyr171 | PASC | C1/C4 | Proposed peroxide ion near active site. Tyr24 oxidation. | Li |
| AA9 |
|
|
| 2 | 1.4 mg ml−1 | 0.2 |
| 1.56 | Copper(I) | His1, His83, Tyr166 | PASC, cellooligosaccharides, xyloglucan, glucomannan, β-glucan | C4 | — | Borisova |
| AA9 |
|
|
| 2 | 1.4 mg ml−1 | 0.2 |
| 1.90 | Zinc(II) | His1, His83, Tyr166 | PASC, cellooligosaccharides, xyloglucan, glucomannan, β-glucan | C4 | — | Borisova |
| AA9 |
|
|
| 2 | 12 mg ml−1, 0.01 | 2.1 |
| 1.75 | Copper(I) | His1, His76, Tyr160 | PASC, Avicel | C1 | — | Wu |
| AA9 |
|
|
| 1 | 15 mg ml−1, 0.02 | 0.2 |
| 1.25 | Copper(II)/copper(I); | MeHis1, His86, Tyr175 | PASC, PCS | C1/C4 | Crystal soaked in 10 m | Quinlan |
| AA9 |
|
|
| 2 | 15 mg ml−1, 0.02 | 0.2 |
| 1.50 | Copper 0.2 | MeHis1, His86, Tyr175 | PASC, PCS | C1/C4 | Quinlan | |
| AA9 |
|
|
| 4 | 3.1 mg ml−1 (pH 7.6–5.0) | 1.6 |
| 2.25 | Zinc(II) | His1, His68, Tyr153 | PASC, Avicel | C1 | Crystal soaked in 1.8 | Harris |
| AA9 |
|
|
| 4 | 3.1 mg ml−1 (pH 7.6–5.0) | 1.6 |
| 1.90 | Magnesium(II) | His1, His68, Tyr153 | PASC, Avicel | C1 | — | Harris |
| AA9 |
|
|
| 2 | 2.2 mg ml−1, 0.02 | 15–20%( |
| 1.60 | Nickel(II) | His1, His89, Tyr176 | Cellulose | N/D | — | Karkehabadi |
| AA10 |
|
|
| 2 | 7.0 mg ml−1, 0.02 | 0.1 |
| 1.80 | — | His28, His125, Phe196 | N/D | N/D | Likely to be active on chitin. | Hemsworth, Davies |
| AA10 |
|
|
| 2 | 7.0 mg ml−1, 0.02 | 0.1 |
| 1.90 | Copper(I) | His28, His125, Phe196 | N/D | N/D | 1 m | Hemsworth, Davies |
| AA10 |
|
|
| 2 | 7.0 mg ml−1, 0.02 | 0.1 |
| 1.70 | Copper(I) | His28, His125, Phe196 | N/D | N/D | — | Hemsworth, Davies |
| AA10 |
|
|
| 6 | 21 mg ml−1 | 0.1 |
| 2.00 | — | His19, His122, Phe205 | N/D | N/D | Mentioned in Book | To be published |
| AA10 |
|
|
| 3 | 9 mg ml−1, 0.02 | 0.1 |
| 1.85 | Copper(I) [copper(II) in chain | His37, His136, Phe205 | α-Chitin, β-chitin | C1 | Copper(II)-saturated sample. | Forsberg |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 1.0 |
| 0.95 | — | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | — | Vaaje-Kolstad |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.1 |
| 1.49 | Copper(II) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 m | Gudmundsson ( |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.1 |
| 1.48 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 m | Gudmundsson ( |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.1 |
| 1.48 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 m | Gudmundsson ( |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.1 |
| 1.49 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 m | Gudmundsson ( |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.1 |
| 1.47 | Copper(II)/copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 m | Gudmundsson ( |
| AA10 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.1 |
| 1.49 | Copper(I) | His29, His114, Phe185 | α-Chitin, β-chitin | C1 | Preincubated with 1 m | Gudmundsson ( |
| AA10 |
|
|
| 2 | 20 mg ml−1, 0.02 | 1.9 |
| 1.55 | Copper(I) | His32, His109, Phe164 | α-Chitin, β-chitin | C1 | — | Mekasha |
| AA10 |
|
|
| 3 | 20 mg ml−1, 0.05 | 1.26 |
| 1.55 | Na2+ | His28, His114, Phe187 | α-Chitin, β-chitin | C1 | Chain | Vaaje-Kolstad, Houston |
| AA10 |
|
|
| 2 | 17.5 mg ml−1, 0.05 | 20%( |
| 1.80 | — | His28, His114, Phe187 | α-Chitin, β-chitin | C1 | Y54A mutant. | Vaaje-Kolstad, Houston |
| AA10 |
|
|
| — | 0.8–1.2 m | pH 5.5 | — | — | — | His28, His114, Phe187 | α-Chitin, β-chitin | C1 | NMR structure. | Aachmann |
| AA10 |
|
|
| 1 | 10.3 mg ml−1, 0.02 | 0.2 |
| 1.29 | Copper(II)/copper(I) 0.95 | His43, His150, Tyr219 | PASC, Avicel, β-chitin | C1/C4 (C1 on chitin) | Soaked in 1–20 m | Forsberg, Mackenzie |
| AA10 |
|
|
| 1 | 10.3 mg ml−1, 0.02 | 0.2 |
| 1.40 | Zinc(II) 0.8 | His43, His150, Tyr219 | PASC, Avicel, β-chitin | C1/C4 (C1 on chitin) | — | Forsberg, Mackenzie |
| AA10 |
|
|
| 8 | 9.2 mg ml−1, 0.02 | 9%( |
| 1.50 | Copper(II)/copper(I) 0.5 | His35, His144, Phe219 | PASC, Avicel | C1 | — | Forsberg, Mackenzie |
| AA10 |
|
|
| 1 | 15 mg ml−1, 0.01 | 0.1 |
| 1.38 | Copper(I) 0.8 | His30, His120, Phe193 | β-Chitin | C1/(C4) | Definite C1 oxidation Indications of C4 oxidation. | Chaplin |
| AA10 |
|
|
| 2 | — | 0.1 |
| 2.00 | Copper(I) 0.5 | His37, His144, Tyr213 | PASC, Avicel, β-chitin | C1/C4 (C1 on chitin) | Regiospecificity in Forsberg, Mackenzie | To be published |
| AA10 |
|
|
| 2 | 2 mg ml−1, 0.02 | 0.2 |
| 1.80 | — | His24, His121, Phe193 | N/D | N/D | — | Wong |
| AA10 |
| Fusolin (ACV034) |
| 1 | — |
|
| 1.90 | — | His1, His142, Phe225 | N/D | N/D | Intracellular fusolin microcrystals from EPV-infected larvae of | Chiu |
| AA10 | Unidentified entomopoxvirus | Fusolin (partial) |
| 1 | — |
|
| 2.02 | Zinc(II) | His1, His222 | N/D | N/D | Intracellular fusolin microcrystals from EPV-infected larvae of | Chiu |
| AA10 | Unidentified entomopoxvirus ( | Fusolin |
| 1 | — |
|
| 1.90 | (H2O) | His1, His142, Phe225 | N/D | N/D | Active-site water molecule may be a low-occupied metal ion. Chitin-binding domain. Mutations: G25D, H192N, I351N, I352H, Q353T, D354G. | Chiu |
| AA10 | Unidentified entomopoxvirus ( | Fusolin |
| 1 | — |
|
| 2.40 | Copper(II) 0.79 | His1, His142, Phe225 | N/D | N/D | Soaked with CuSO4. | Chiu |
| AA10 | Unidentified entomopoxvirus ( | Fusolin |
| 1 | — |
|
| 2.41 | Zinc(II) | His1, His142, Phe225 | N/D | N/D | Soaked with ZnSO4. | Chiu |
| AA11 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.01 |
| 1.55 | Zinc(II) | His1, His60, Tyr140 | β-Chitin | C1 | — | Hemsworth |
| AA11 |
|
|
| 1 | 25 mg ml−1, 0.02 | 0.01 |
| 1.40 | Copper(I) | His1, His60, Tyr140 | β-Chitin | C1 | Soaked in 2 m | Hemsworth |
| AA13 |
|
|
| 1 | 3 mg ml−1, 0.02 | 0.14 |
| 1.55 | Copper(I) | MeHis1, His91, Tyr224 | N/D (starch) | N/D (C1) | Enzymes with 70–72% sequence identity [ | Lo Leggio |
Number of molecules in the asymmetric unit.
The criteria for assigning a copper(II) or copper(I) state were informed by structures where both states have been characterized (Gudmundsson et al., 2014 ▸). The electron density of the equatorial exogenous ligand to the copper (from weighted 2F obs − F calc) should be more than 2σ with more than 0.5 occupancy and a distance to the copper of less than 2.4 Å, with similar criteria applying to the exogenous axial ligand, although with a distance of 2.8 Å. In structures where a distorted geometry is observed because of significant steric effects (most AA10 members), structures with a single exogenous ligand within 2.5 Å distance are taken as copper(II). The occupancy of the metal is 1.00 if no other value is indicated. If there is significant metal-site disorder with characteristics that could fit both states, the site is described as copper(II)/copper(I). When the copper occupancy was lower than 0.5, no oxidation state was assigned.
Figure 2Overall view of selected AA10 structures and the closest non-LPMO structural relative. The structurally common central β-cores are coloured yellow, while distinct structural elements are coloured differently for each structure. (a) SmAA10_A with the (‘budded’) helical insert in cyan and elements differing compared with JdAA10_A indicated in red. (b) JdAA10_A with the helical insert in blue. (c) The closest non-LPMO structural homologue (the MG2 domain of human α2-macroglobulin; PDB entry 2p9r) with a small helical segment in green. (d) Fusolin (Melolontha melolontha entomopoxvirus; PDB entry 4ow5) with a number of helical segments in magenta.
Figure 3The copper-binding site in LPMOs. (a) The copper(II)-binding site (PDB entry 4alc) and (b) the photoreduced copper(I)-binding site (PDB entry 4alt) of EfAA10_A. (c) The copper(II)-binding site (PDB entry 5acg) and (d) the partially photoreduced copper(II)/(I)-binding site (PDB entry 5ach) of LsAA9_A. The copper spheres are in cyan to indicate copper(II) and in a copper colour to indicate copper(I). All electron-density maps (2F o − F c) are contoured at the 1.5σ level. (e) Superposition of all structurally characterized copper-loaded LPMOs. AA9 members (PDB entries 4eir, 4qi8, 4eis, 4d7u, 4b5q, 3zud and 5ach) are shown in green, AA10 members (PDB entries 5fjq, 4alt, 5aa7, 4oy6, 4oy7, 5ftz, 4gbo and 4x27) in yellow, AoAA11 (PDB entry 4mai) in cyan and AoAA13 (PDB entry 4opb) in magenta. See Table 1 ▸ for the protein names of the AA9 and AA10 members.
Figure 4Substrate binding by LsAA9_A. (a) Top and side view of G6 binding in LsAA9_A (PDB entry 5aci): LsAA9_A is shown in grey with the loops L2, L3, LS and LC coloured yellow, green, red and blue, respectively. The cellohexaose substrate, the His brace and selected substrate-interacting residues are shown as sticks. Residues are coloured in accordance with the structural elements to which they belong. (b) Comparison of glycoside units binding at the −2/+1 subsite in LsAA9_A (bottom; PDB entry 5acf) and the Michaelis–Menten complex of endoglucanase Cel5A from Bacillus agaradhaerens with 2′,4′-dinitrophenyl-2-deoxy-2-fluoro-β-d-cellobioside (PDB entry 4a3h; Davies et al., 1998 ▸). (c) Comparison of the active sites of LsAA9_A (with protein in green and waters in red; PDB entry 5acg) and TtAA9_E (PDB entry 3eii; chain B; all in grey). The glucosyl unit in subsite +1 of LsAA9_A–copper(II)–G3 (PDB entry 5acf) is superimposed and shown in yellow.
Figure 5Features of the substrate-binding surfaces of LPMOs. (a) Surface of TaAA9_A (PDB entry 3zud) with tyrosines at the substrate-binding surface coloured yellow. (b) Surface of LsAA9_A (PDB entry 5aci) with Tyr203 in yellow and the L3 loop in green, with His66 and Asn67 in stick representation. (c) Surface of AoAA13 with a groove spanning the active site. In all cases the N-terminal histidine (His1) of the histidine brace is shown in stick representation and coloured cyan and the coppers are shown as spheres.